Masafumi Kurosumi Selected Research

Masafumi Kurosumi Research Topics

Disease

91	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2002
66	Neoplasms (Cancer) 02/2022 - 01/2003
15	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2007
5	Carcinoma (Carcinomatosis) 11/2012 - 01/2002
4	Triple Negative Breast Neoplasms 11/2019 - 03/2011
3	Disease Progression 06/2018 - 02/2014
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2017 - 12/2013
3	Carcinogenesis 07/2017 - 08/2009
3	Lymphatic Metastasis 07/2017 - 09/2015
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 06/2012 - 08/2009
3	Neutropenia 08/2008 - 01/2006
2	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2021 - 12/2003
2	Hepatocellular Carcinoma (Hepatoma) 07/2017 - 05/2008
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 05/2008
2	Stomach Neoplasms (Stomach Cancer) 11/2012 - 11/2011
2	Pathologic Complete Response 02/2012 - 01/2006
2	Intestinal Neoplasms (Intestinal Cancer) 11/2011 - 08/2009
2	Margins of Excision 03/2010 - 08/2009
2	Edema (Dropsy) 10/2007 - 01/2005
2	Febrile Neutropenia 10/2007 - 10/2006
2	Ductal Carcinoma 01/2007 - 07/2003
2	Leukopenia 10/2006 - 01/2006
1	Residual Neoplasm 01/2019
1	Alopecia (Baldness) 06/2018
1	Multiple Endocrine Neoplasia Type 1 11/2017
1	Neuroblastoma 07/2017

Drug/Important Bio-Agent (IBA)

23	Estrogen ReceptorsIBA 09/2021 - 06/2004
20	Hormones (Hormone)IBA 09/2021 - 01/2003
17	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2006
14	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 01/2006
12	ErbB Receptors (EGF Receptor)IBA 09/2021 - 12/2007
12	Docetaxel (Taxotere)FDA Link 09/2015 - 01/2005
10	Estrogens (Estrogen)FDA Link 03/2018 - 06/2004
9	human ERBB2 proteinIBA 01/2022 - 10/2008
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2021 - 01/2005
9	Proteins (Proteins, Gene)FDA Link 06/2019 - 01/2009
8	Epirubicin (Ellence)FDA LinkGeneric 09/2015 - 01/2005
6	Phenobarbital (Luminal)FDA Link 01/2022 - 12/2007
6	Fluorouracil (Carac)FDA LinkGeneric 02/2021 - 01/2005
6	Paclitaxel (Taxol)FDA LinkGeneric 06/2018 - 01/2007
6	Aromatase InhibitorsIBA 01/2018 - 06/2005
4	Messenger RNA (mRNA)IBA 02/2022 - 12/2012
4	Biomarkers (Surrogate Marker)IBA 10/2019 - 07/2010
4	AnthracyclinesIBA 01/2017 - 01/2010
4	taxaneIBA 01/2017 - 01/2006
4	Tamoxifen FDA LinkGeneric 04/2011 - 10/2007
3	exemestane (Aromasin)FDA Link 09/2021 - 01/2008
3	Biological ProductsIBA 03/2019 - 12/2007
3	Epidermal Growth Factor (EGF)IBA 07/2017 - 01/2006
3	Taxoids (Taxanes)IBA 09/2015 - 01/2006
3	Insulin (Novolin)FDA Link 08/2014 - 11/2011
3	Green Fluorescent ProteinsIBA 01/2014 - 06/2005
3	AndrogensIBA 01/2014 - 11/2006
3	SteroidsIBA 01/2014 - 01/2003
3	Formaldehyde (Formol)FDA Link 11/2013 - 10/2008
3	Keratin-5 (Keratin 5)IBA 03/2011 - 12/2007
3	Tumor Biomarkers (Tumor Markers)IBA 05/2008 - 01/2003
2	antineoplaston A10 (A 10)IBA 09/2021 - 08/2010
2	UracilIBA 02/2021 - 10/2007
2	TegafurIBA 02/2021 - 10/2007
2	Bevacizumab (Avastin)FDA Link 06/2018 - 01/2017
2	eribulin FDA Link 06/2018 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2017
2	LigandsIBA 12/2017 - 08/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 06/2008
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2016 - 08/2009
2	Aromatase (CYP19)IBA 01/2014 - 06/2005
2	Testosterone (Sustanon)FDA Link 06/2013 - 06/2005
2	ParaffinIBA 10/2010 - 10/2008
2	Keratins (Keratin)IBA 06/2009 - 01/2007
2	EnzymesIBA 10/2007 - 06/2005
2	Coloring Agents (Dyes)IBA 01/2006 - 01/2006
2	thiamine triphosphorate (TTP)IBA 01/2006 - 01/2003
2	Thymidine PhosphorylaseIBA 08/2004 - 01/2002
1	RNA (Ribonucleic Acid)IBA 02/2022
1	Large Neutral Amino Acid-Transporter 1IBA 01/2022
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2021
1	Methotrexate (Mexate)FDA LinkGeneric 02/2021
1	B7-H1 AntigenIBA 11/2019
1	Cyclin D1IBA 01/2019
1	Fulvestrant (Faslodex)FDA Link 01/2019
1	Progesterone FDA LinkGeneric 03/2018
1	Letrozole (Femara)FDA LinkGeneric 01/2018
1	Immune Checkpoint InhibitorsIBA 12/2017
1	activin AIBA 07/2017

Therapy/Procedure

48	Therapeutics 01/2022 - 01/2002
17	Neoadjuvant Therapy 01/2019 - 01/2005
14	Drug Therapy (Chemotherapy) 12/2017 - 01/2005
6	Radiotherapy 07/2017 - 09/2006
6	Mastectomy (Mammectomy) 05/2015 - 01/2007
5	Adjuvant Chemotherapy 07/2022 - 07/2003
5	Segmental Mastectomy (Lumpectomy) 06/2013 - 01/2005
4	Lymph Node Excision (Lymph Node Dissection) 01/2010 - 01/2007
3	Gastrectomy 11/2017 - 11/2011
3	Colectomy 11/2012 - 11/2010
2	Pancreatectomy 11/2012 - 11/2011
2	Molecular Targeted Therapy 11/2012 - 01/2009
1	Duration of Therapy 09/2021
1	Lasers (Laser) 06/2019